Melanoma StemnessHIGH patients are characterized with worse prognosis (p < 0.0001) (Figure 2F) and TRIM28 expression significantly predicts the classification to “stemness high” cohort, either discriminated with the Ben–Porath ES core signature (p < 0.0001) (Figure 2G) or other stem-cell associated gene signatures (Figure 2H). Here, TRIM28 is linked to melanoma.